18FDG for the study of central nervous system drugs

Journal of Clinical Pharmacology

Volumn 41, Issue 7 SUPPL., 2001, Pages

  Fowler, Joanna S ^a   Volkow, Nora D ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; CENTRAL NERVOUS SYSTEM AGENTS; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CYCLOTRON; DRUG RESEARCH; DRUG SYNTHESIS; FLUORINATION; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; NEUROSCIENCE; ANIMAL; ARTICLE; HUMAN;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; FLUORODEOXYGLUCOSE F18; HUMANS; RADIOPHARMACEUTICALS;

EID: 0034743487     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127001773744107     Document Type: Conference Paper

References (8)

1. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man
2. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
3. 18F-labeled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: Tissue distribution and imaging studies in animals
4. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection
5. 14C-2-deoxy-2-fluoro-D-glucose
6. 18F reaction
7. 18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
8. PET and drug research and development